Nclex RN

When administering Digoxin, nurses must be vigilant in monitoring specific laboratory results to ensure client safety and effectiveness of the medication. Digoxin is a cardiac glycoside used to treat heart failure and certain arrhythmias by increasing the force of myocardial contraction and regulating heart rate. However, its therapeutic range is narrow, making monitoring paramount. One of the key laboratory values to monitor closely is the serum potassium level. Hypokalemia (low potassium) can increase the risk of Digoxin toxicity, which may lead to dangerous arrhythmias. Conversely, hyperkalemia (high potassium) can decrease Digoxin's efficacy. Thus, maintaining potassium within a normal range is critical during Digoxin therapy. Other electrolytes such as serum sodium and calcium are important but less directly associated with Digoxin toxicity. Monitoring calcium is important because hypercalcemia can exacerbate Digoxin's effects on the heart, but it is less commonly a lab value prioritized. Serum sodium levels are important in overall fluid and electrolyte balance but do not have a direct impact on Digoxin toxicity. In addition to laboratory monitoring, nurses should assess for clinical signs of Digoxin toxicity, such as gastrointestinal symptoms (nausea, vomiting), visual disturbances (blurred or yellow vision), and cardiac arrhythmias. Educating clients about adherence, diet, and recognizing symptoms is vital. For NCLEX RN test takers, understanding the relationship between Digoxin administration and electrolyte monitoring—especially potassium—is a recurring theme in pharmacology questions. This knowledge improves patient safety and ensures optimal therapeutic outcomes in clinical settings.